Amphastar Pharmaceuticals, Inc. (AMPH) — Fair Value Analysis

Base-case fair value (P50): $25.78 · Current price: $21.03 · Verdict: Undervalued

The Verdict on AMPH

Our Monte Carlo simulations indicate AMPHASTAR PHARMACEUTICALS INC (AMPH) is currently Fairly Valued. Trading at $21.03, AMPH shows a median fair value (P50) of $25.78. This suggests an +22.6% potential based on our probabilistic models, placing AMPH squarely within its expected valuation range. For investors evaluating AMPH, this outcome reflects a balance of current market price against a wide range of future fundamental scenarios, suggesting neither significant overvaluation nor undervaluation at present. The quantitative models, running thousands of simulations, converge to this median fair value, providing a data-driven perspective on AMPH's current standing relative to its intrinsic value.

How AMPH stacks up against Healthcare

As a Healthcare sector constituent, AMPH's operational and financial health is currently rated as "average." This "average" quality tier suggests AMPH maintains a competitive position within its sector, without exhibiting notable strengths or weaknesses that would dramatically skew its fair value in either direction. The +22.6% from its current price of $21.03** to the P50 fair value of $25.78 aligns with what might be expected for an average-quality company in the Healthcare sector, where growth and stability factors are balanced. While an "average" rating doesn't imply exceptional short-term catalysts, it does suggest a stable foundational profile for its long-term fair value.

What this means for investors

Given AMPH's "Fairly Valued" verdict and "average" quality tier, investors should view the +22.6% to $25.78 from $21.03 as a reflection of the company's current intrinsic worth. While a bull case scenario could see appreciation beyond this, a downside scenario remains a possibility, as with any equity. The Monte Carlo framework accounts for these various pathways, but the P50 remains the central tendency. FairCurve's analysis, therefore, suggests that AMPH's current market price is a reasonable representation of its expected valuation. To understand the full distribution of potential outcomes, including the bear (P10) and bull (P90) case scenarios, and track AMPH's fair value as new fundamentals are released, sign up for a free FairCurve account.